Patents by Inventor Ansar A. Pathan

Ansar A. Pathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7850979
    Abstract: A method for generating a T cell immune response in a host involving administering a vectored vaccine comprising a non-replicating or replication impaired viral vector expressing the translation product of a mycobacterial antigen 85A gene. Vectored vaccines and uses thereof are also provided. Also provided is a method of inducing a CD8 and a CD4 memory T cell response against an antigen using an adenovirus vector expressing an antigen or an immunogenic fragment thereof.
    Type: Grant
    Filed: January 5, 2006
    Date of Patent: December 14, 2010
    Assignee: Isis Innovation Limited
    Inventors: Helen McShane, Ansar A. Pathan, Adrian Hill, Sarah C. Gilbert
  • Publication number: 20080226678
    Abstract: A method for generating a T cell immune response in a host involving administering a vectored vaccine comprising a non-replicating or replication impaired viral vector expressing the translation product of a mycobacterial antigen 85A gene. Vectored vaccines and uses thereof are also provided. Also provided is a method of inducing a CD8 and a CD4 memory T cell response against an antigen using an adenovirus vector expressing an antigen or an immunogenic fragment thereof.
    Type: Application
    Filed: January 5, 2006
    Publication date: September 18, 2008
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Helen McShane, Ansar A. Pathan, Adrian Hill, Sarah C. Gilbert
  • Patent number: 7115361
    Abstract: A method of detecting an anti-mycobacterial CD8 T cell response comprising contacting a population of CD8 T cells of an individual with one or more peptides selected from the peptides represented by SEQ ID NO: 3, 4, 7, 8, 9, 10, 11 or 12, and, optionally, one or two further peptides represented by SEQ ID NO: 1 and/or 2, wherein one or more of said peptides may be substituted by an analogue which binds a T cell receptor which recognises the corresponding substituted peptide, and determining whether CD8 T cells of the CD8 T cell population recognize the peptide(s).
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: October 3, 2006
    Assignee: Isis Innovation Limited
    Inventors: Ajit Lalvani, Ansar A. Pathan
  • Publication number: 20040141985
    Abstract: A method of detecting an anti-mycobacterial CD8 T cell response comprising contacting a population of CD8 T cells of an individual with one or more peptides selected from the peptides represented by SEQ ID NO: 3, 4, 7, 8, 9, 10, 11 or 12, and, optionally, one or two further peptides represented by SEQ ID NO: 1 and/or 2, wherein one or more of said peptides may be substituted by an analogue which binds a T cell receptor which recognises the corresponding substituted peptide, and determining whether CD8 T cells of the CD8 T cell population recognize the peptide(s).
    Type: Application
    Filed: November 26, 2003
    Publication date: July 22, 2004
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Ajit Lalvani, Ansar A. Pathan
  • Publication number: 20020131976
    Abstract: A method of detecting an anti-mycobacterial CD8 T cell response comprising contacting a population of CD8 T cells of an individual with one or more peptides selected from the peptides represented by SEQ ID NO: 3, 4, 7, 8, 9, 10, 11 or 12, and, optionally, one or two further peptides represented by SEQ ID NO: 1 and/or 2, wherein one or more of said peptides may be substituted by an analogue which binds a T cell receptor which recognises the corresponding substituted peptide, and determining whether CD8 T cells of the CD8 T cell population recognize the peptide(s).
    Type: Application
    Filed: July 27, 2001
    Publication date: September 19, 2002
    Inventors: Ajit Lalvani, Ansar A. Pathan, Adrian V.S. Hill